2022-07-14T11:30:25-05:00 2020-12-31 371611326 ARONSON LLC 111 ROCKVILLE PIKE SUITE 600 ROCKVILLE MD 20850 990 2020-07-13 852130952 Accumulus Synergy Inc ACCU 8006486438 1534 Plaza Lane 210 Burlingame CA 94010 FRANCISCO NOGUEIRA CEO 2022-07-14 true FRANCISCO NOGUEIRA 999009999 ROBERT EBY CPA P01682202 3012316200 2020 2022-09-23 18:48:47Z X FRANCISCO NOGUEIRA 1534 Plaza Lane 210 Burlingame CA 94010 23985066 false X www.accumulus.org X 2020 DE Accumulus Synergy Inc. will dramatically accelerate the availability of critical therapies to citizens of the world by reimagining the interaction and information exchange between stakeholders in the healthcare ecosystem to streamline the regulatory lifecycle. Accumulus Synergy solutions facilitate real-time, simultaneous, and global submissions, reviews, and assessments of therapies 10 10 0 164 0 0 23985000 0 66 0 0 23985066 0 0 0 0 0 1627419 1627419 0 22357647 0 23477396 0 1119749 0 22357647 We are developing a global information exchange platform to transform how drug innovators and health regulators interact to bring safe and effective medicines to patients faster and more efficiently. false 1627419 In the first year of operations Accumulus accomplished the following i. Mobilized the entity with 10 contributing members ii. Secured the board iii. Authored and approved several corporate policies iv. Mobilized and operated several working groups to identify initial use cases for software development 1. Data Governance 2. Chemistry Manufacturing and Controls 3. Pharmacovigilance 4. Parallel Review v. Formally engaged several health authorities to participate in Accumulus at varying levels of formality. 1. PPP with FDA was started, but not executed till 2021 2. EMA - European Medicines Agency 3. PMDA - Japan 4. MHRA - UK 5. Others vi. Conducted an RFP to identify and shortlist cloud service providers and s/w development firms to support our platform build 1627419 false false false true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true 2 0 true 0 false false false false true true false false false X 10 10 false false false false true true false true false false true true true true true true false false false DE X FRANCISCO NOGUEIRA 8006486438 1534 Plaza Lane Burlingame Suite CA 94010 X Aditi Kumar Director 1.5 X 0 0 0 Eddie Reilly Director 1.5 X 0 0 0 Helen Fitton Director 1.5 X 0 0 0 Jeremy Chadwick Director/Chair 1.5 X 0 0 0 Jerry Stewart Director 1.5 X 0 0 0 Karin van Baelen Director 1.5 X 0 0 0 Mark Taisey Director 1.5 X 0 0 0 Michael Robbins Director 1.5 X 0 0 0 Pandurang Kulkarni Director 1.5 X 0 0 0 Susanne Gronen Director 1.5 X 0 0 0 Francisco Nogueira CEO since 10/1/2020 40.0 X 0 0 0 Mark Bach CEO until 11/1/2020 1.5 X 0 0 0 Thomas McCormick COO until 12/31/2020 1.5 X 0 0 0 0 0 0 0 false false false Deloitte Consulting LLP PO Box 844717 Dallas TX 752844717 consulting 1184375 Covington & Burling LLP One City Center 850 Tenth Street NW Washington DC 20001 legal services 303357 2 0 23985000 0 0 0 0 0 23985000 0 0 0 0 0 66 66 0 0 0 0 0 0 0 0 0 23985066 0 0 66 X 303357 95 1289375 33920 672 0 1627419 0 12647330 0 6500066 0 4330000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23477396 0 1119749 0 0 0 0 0 0 0 0 0 0 0 1119749 X 0 22357647 0 0 0 22357647 0 23477396 22357647 0 0 0 0 0 X false false false true true Form 990, Part VI, Line 6 Classes of members or stockholders There is one class of voting members that is open to any biopharmaceutical entity interested in supporting the mission and purpose of Accumulus. Additionally, there is one class of nonvoting members, which consists of any person or entity that similarly support's Accumulus' mission. Form 990, Part VI, Line 7a Members or stockholders electing members of governing body Voting members, as described above, have the right to appoint an individual to serve as a director. Form 990, Part VI, Line 11b Review of form 990 by governing body The Form 990 is prepared by an accounting firm. All members of the board are provided a copy of the draft 990 to review in advance of the board meeting where the return is discussed. After the board discusses the 990 it then votes to approve the 990. After the board votes to approve the 990 it is filed. Form 990, Part VI, Line 12c Conflict of interest policy Pursuant to the conflict of interest policy, the board of directors monitors and enforces compliance with the conflict of interest policy. Officers, directors, and key employees are required to disclose any transaction that may result in a potential conflict of interest. A potentially conflicted person may make a presentation to the board at a meeting where the transaction is deliberated, but must leave the meeting and not take part in any discussion of, or vote on, the transaction. Form 990, Part VI, Line 19 Required documents available to the public Governing documents and financial statements will be made available upon request. Form 990, Part IX, Line 11g Other Fees Consulting - Total Expense: 1184375, Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; Recruiting and HR - Total Expense: 105000, Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ;